Category
    Regions
    Category
    Regions
    Reset Showing 1 – 10 of 10
    Zur Rose Group AG SWOT, Financial and Strategic Analysis Report 2025

    Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. It offers consumer health, beauty, and personal care products. The company also provides medicines management services. It operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Zur Rose Group AG. Zur Rose Group AG business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Zur Rose Group AG are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of Zur Rose Group AG , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of Zur Rose Group AG including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Zur Rose Group AG and all latest updates of the company are provided. The 2025 version of Zur Rose Group AG report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Nov-2025

    $50
    $50
    $50
    SunLink Health Systems Inc. SWOT, Financial and Strategic Analysis Report 2025

    SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of SunLink Health Systems Inc.. SunLink Health Systems Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of SunLink Health Systems Inc. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of SunLink Health Systems Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of SunLink Health Systems Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of SunLink Health Systems Inc. and all latest updates of the company are provided. The 2025 version of SunLink Health Systems Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Sep-2025

    $50
    $50
    $50
    SHOP APOTHEKE EUROPE INH. SWOT, Financial and Strategic Analysis Report 2025

    Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of SHOP APOTHEKE EUROPE INH.. SHOP APOTHEKE EUROPE INH. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of SHOP APOTHEKE EUROPE INH. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of SHOP APOTHEKE EUROPE INH. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of SHOP APOTHEKE EUROPE INH. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of SHOP APOTHEKE EUROPE INH. and all latest updates of the company are provided. The 2025 version of SHOP APOTHEKE EUROPE INH. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Sep-2148

    $50
    $50
    $50
    PetMed Express Inc. SWOT, Financial and Strategic Analysis Report 2025

    PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of PetMed Express Inc.. PetMed Express Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of PetMed Express Inc. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of PetMed Express Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of PetMed Express Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of PetMed Express Inc. and all latest updates of the company are provided. The 2025 version of PetMed Express Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Jan-1970

    $50
    $50
    $50
    Oriola Oyj A SWOT, Financial and Strategic Analysis Report 2025

    Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well as the grocery trade shops. In addition, the company offers pharmaceutical staffing and dose dispensing services for public and private healthcare operators, pharmacies, groceries, veterinarians, and retailers. As of December 31, 2021, it operated 319 pharmacies in Sweden, as well as operates online pharmacies. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. Oriola Oyj is headquartered in Espoo, Finland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Oriola Oyj A. Oriola Oyj A business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Oriola Oyj A are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of Oriola Oyj A , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of Oriola Oyj A including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Oriola Oyj A and all latest updates of the company are provided. The 2025 version of Oriola Oyj A report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Jan-1970

    $50
    $50
    $50
    Neighbourly Pharmacy Inc. SWOT, Financial and Strategic Analysis Report 2025

    Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies in 275 locations under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Neighbourly Pharmacy Inc.. Neighbourly Pharmacy Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Neighbourly Pharmacy Inc. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of Neighbourly Pharmacy Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of Neighbourly Pharmacy Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Neighbourly Pharmacy Inc. and all latest updates of the company are provided. The 2025 version of Neighbourly Pharmacy Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Jan-1970

    $50
    $50
    $50
    MedAvail Holdings Inc. SWOT, Financial and Strategic Analysis Report 2025

    MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of MedAvail Holdings Inc.. MedAvail Holdings Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of MedAvail Holdings Inc. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of MedAvail Holdings Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of MedAvail Holdings Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of MedAvail Holdings Inc. and all latest updates of the company are provided. The 2025 version of MedAvail Holdings Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Jan-1970

    $50
    $50
    $50
    LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock SWOT, Financial and Strategic Analysis Report 2025

    LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock. LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock and all latest updates of the company are provided. The 2025 version of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Jan-1970

    $50
    $50
    $50
    HealthWarehouse.com, Inc. SWOT, Financial and Strategic Analysis Report 2025

    HealthWarehouse.com, Inc. operates an online and mail order pharmacy. The company markets a range of generic, brand name, and pet prescription medicines, as well as over-the-counter (OTC) medications and products. It sells its products in 50 states and the District of Columbia in the United States to focus on the out-of-pocket prescription drug market. The company sells prescription medications and OTC products to individual consumers over the Internet. HealthWarehouse.com, Inc. is headquartered in Florence, Kentucky. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of HealthWarehouse.com, Inc.. HealthWarehouse.com, Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of HealthWarehouse.com, Inc. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of HealthWarehouse.com, Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of HealthWarehouse.com, Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of HealthWarehouse.com, Inc. and all latest updates of the company are provided. The 2025 version of HealthWarehouse.com, Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Aug-2025

    $50
    $50
    $50
    Fire & Flower Holdings Corp. SWOT, Financial and Strategic Analysis Report 2025

    Fire & Flower Holdings Corp. operates as an independent cannabis retailer in Canada and the United States. It sells and distributes cannabis products and accessories to the adult-use market through private retailers, as well as under the Fire & Flower, Friendly Stranger, Happy Dayz, and Hotbox retail banners. The company also operates Hifyre digital retail and analytics platform; Spark Perks customer loyalty program; cannabis websites and content platforms under the PotGuide and Wikileaf names; and Pineapple Express, a delivery platform. As of June 14, 2022, it had approximately 100 stores. The company is headquartered in Toronto, Canada. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Fire & Flower Holdings Corp.. Fire & Flower Holdings Corp. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Fire & Flower Holdings Corp. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of Fire & Flower Holdings Corp. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of Fire & Flower Holdings Corp. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Fire & Flower Holdings Corp. and all latest updates of the company are provided. The 2025 version of Fire & Flower Holdings Corp. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

    Published: Aug-2025

    $50
    $50
    $50